4-methoxyamphetamine has been researched along with T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apte, RN; Barak, V; Benharroch, D; Cagnano, E; Dobkin, M; Ofir, R; Segal, S; Voronov, E; Weinstein, Y; White, RM; Zoller, M | 1 |
1 other study(ies) available for 4-methoxyamphetamine and T-Cell Lymphoma
Article | Year |
---|---|
Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
Topics: Animals; Cell Division; Death; Female; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genetic Therapy; Growth Inhibitors; Immunotherapy; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Lipopolysaccharides; Lymphocyte Activation; Lymphokines; Lymphoma, T-Cell; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Paralysis; Recombinant Proteins; Sialoglycoproteins; Spinal Neoplasms; T-Lymphocytes; Tumor Cells, Cultured | 1999 |